Form 8-K - Current report:
SEC Accession No. 0001193125-25-143665
Filing Date
2025-06-20
Accepted
2025-06-20 16:16:26
Documents
14
Period of Report
2025-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d925162d8k.htm   iXBRL 8-K 46100
2 EX-10.1 d925162dex101.htm EX-10.1 239162
3 EX-10.2 d925162dex102.htm EX-10.2 90915
  Complete submission text file 0001193125-25-143665.txt   579599

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstv-20250617.xsd EX-101.SCH 2878
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20250617_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20250617_pre.xml EX-101.PRE 11280
17 EXTRACTED XBRL INSTANCE DOCUMENT d925162d8k_htm.xml XML 3658
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 251061575
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)